Epigenetics Market to Expand at a CAGR of 13.6% from 2018 to 2025 : Top Companies Merck KGaA, Thermo Fisher Scientific, Abcam, Agilent Technologies and Active Motif
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Pune, India -- (SBWire) -- 03/28/2019 --According to a new market research study titled 'Epigenetics Market to 2025 - Global Analysis and Forecasts by Product, Technology, Application and End User. The global epigenetics market is expected to reach US$ 2,611.57 Mn in 2025 from US$ 991.45 in 2017. The market is estimated to grow with a CAGR of 13.6% from 2018-2025. The report highlights the trends prevalent in the global epigenetics market and the factors driving the market along with those that act as deterrents to its growth.
Worldwide Epigenetics Market Analysis to 2025 is a specialized and in-depth study of the Epigenetics Industry with a focus on the global market trend. The report aims to provide an overview of global Epigenetics Market with detailed market segmentation by product/application and geography.
Top Dominating Key Players:
1. Merck KGaA
2. Thermo Fisher Scientific, Inc.
3. Abcam plc
4. Agilent Technologies
5. Active Motif
6. QIAGEN
7. Bio-Rad Laboratories, Inc.
8. PerkinElmer Inc.
9. New England Biolabs (NEB)
10. Illumina, Inc.
Request for Sample Report @ https://www.theinsightpartners.com/sample/TIPHE100000971
Global epigenetics market, based on technology was segmented histone modification, DNA methylation and other technologies. In 2017, DNA methylation segment held the largest share of the market, by technology. The largest share of the DNA methylation is primarily owing to its ability to develop therapies for diseases including cancer, lupus, muscular dystrophy and various congenital defects and also it helps to prevent conditions that develop during embryonic development such as, abnormal methylation of the X-chromosome and gene imprinting.
The market for epigenetics is expected to grow as declining prices of sequencing, increasing prevalence of cancer, funds & grants provided by government bodies are expected to fuel the market growth during the forecast period. In addition, promising precise treatments by neurogenetics are likely to have a positive impact on the growth of the market in the coming years.
The report segments the global epigenetics market as follows:
Global epigenetics Market - By Product
- Reagents
- Kits
- Enzymes
- Instruments & Consumables
Bioinformatics Tools Global epigenetics Market - By Technology
- Histone Modification
- DNA Methylation
- Others
Global epigenetics Market - By Application
- Metabolic Diseases
- Oncology
- Cardiovascular Diseases
- Others
Global Epigenetics Market - By End User
- Academics & Research Institutes
- Contract Research Organizations
- Biotechnology & Pharmaceutical Companies
Inquire about Discount on this Report @ https://www.theinsightpartners.com/discount/TIPHE100000971
Reason to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Global Epigenetics Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Epigenetics, thereby allowing players to develop effective long term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.
Media Relations Contact
Sameer Joshi
CEO
The Insight Partners
1-646-491-9876
https://www.theinsightpartners.com/
View this press release online at: http://rwire.com/1182482